Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q12948: Variant p.Trp152Gly

Forkhead box protein C1
Gene: FOXC1
Feedback?
Variant information Variant position: help 152 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Tryptophan (W) to Glycine (G) at position 152 (W152G, p.Trp152Gly). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and aromatic (W) to glycine (G) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In ASGD3; no change in protein abundance; changed post-translational phosphorylation; changed protein structure; decreased location at the nucleus; novel location at the cytoplasm; increased protein aggregation, aggregation do not correspond to microtubule-dependent inclusion bodies; loss of transcription regulatory region DNA binding; loss of sequence-specific DNA binding transcription factor activity. Any additional useful information about the variant.


Sequence information Variant position: help 152 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 553 The length of the canonical sequence.
Location on the sequence: help LNECFVKVPRDDKKPGKGSY W TLDPDSYNMFENGSFLRRRR The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         LNECFVKVPRDDKKPGKGSYWTLDPDSYNMFENGSFLRRRR

Mouse                         LNECFVKVPRDDKKPGKGSYWTLDPDSYNMFENGSFLRRRR

Xenopus tropicalis            LNECFVKVPRDDKKPGKGSYWTLDPDSYNMFENGSFLRRRR
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 553 Forkhead box protein C1
DNA binding 77 – 168 Fork-head



Literature citations
Severe molecular defects of a novel FOXC1 W152G mutation result in aniridia.
Ito Y.A.; Footz T.K.; Berry F.B.; Mirzayans F.; Yu M.; Khan A.O.; Walter M.A.;
Invest. Ophthalmol. Vis. Sci. 50:3573-3579(2009)
Cited for: VARIANT ASGD3 GLY-152; CHARACTERIZATION OF VARIANT ASGD3 GLY-152; FUNCTION; SUBCELLULAR LOCATION; PHOSPHORYLATION; CHARACTERIZATION OF VARIANT RIEG3 PHE-130;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.